BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumbhar BV, Bhandare VV. Exploring the interaction of Peloruside-A with drug resistant αβII and αβIII tubulin isotypes in human ovarian carcinoma using a molecular modeling approach. Journal of Biomolecular Structure and Dynamics 2021;39:1990-2002. [DOI: 10.1080/07391102.2020.1745689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Pérez-Peña H, Abel AC, Shevelev M, Prota AE, Pieraccini S, Horvath D. Computational Approaches to the Rational Design of Tubulin-Targeting Agents. Biomolecules 2023;13. [PMID: 36830654 DOI: 10.3390/biom13020285] [Reference Citation Analysis]
2 Joshi BP, Bhandare VV, Vankawala M, Patel P, Patel R, Vyas B, Krishnamurty R. Friedelin, a novel inhibitor of CYP17A1 in prostate cancer from Cassia tora. Journal of Biomolecular Structure and Dynamics 2022. [DOI: 10.1080/07391102.2022.2145497] [Reference Citation Analysis]
3 Assiry AA, Bhavikatti SK, Althobaiti FA, Mohamed RN, Karobari MI. Evaluation of In Vitro Antiprotease Activity of Selected Traditional Medicinal Herbs in Dentistry and Its In Silico PASS Prediction. Biomed Res Int 2022;2022:5870443. [PMID: 35707383 DOI: 10.1155/2022/5870443] [Reference Citation Analysis]
4 Maloney SM, Hoover CA, Morejon-Lasso LV, Prosperi JR. Mechanisms of Taxane Resistance. Cancers (Basel). 2020;12. [PMID: 33182737 DOI: 10.3390/cancers12113323] [Cited by in Crossref: 42] [Cited by in F6Publishing: 49] [Article Influence: 14.0] [Reference Citation Analysis]